reduce insulin dose when starting glp-1 receptor agonist Drugs and Type 1 Diabetes: Less Insulin, Better Time in Range — What the Evidence GLP-1 Receptor Agonists & Weight

MROs are required components of DOT-mandated drug testing programs and are widely used in non-DOT programs as well

Investigators compared three therapeutic combinationsGLP1/estrogen (GLP1/E), GLP1/gastric inhibitory peptide (GLP1/GIP), and GLP1/GIP/glucagonacross two mouse models of PCOS with differing reproductive and metabolic profiles

Microbes like Coprococcus and Faecalibacterium also produce acetate, butyrate, and propionate, which are known to affect the immune, endocrine, and nervous systems (Valles-Colomer et al., 2019)

Avoid Additives : Homemade drinks eliminate the risk of preservatives and artificial ingredients that are often found in commercial beverages

The data is striking: in a Phase 2 trial published in the New England Journal of Medicine, the highest doses produced an average ~24% body-weight reduction at 11 months more than any currently approved weight-loss drug (American Diabetes Association)

The control of methemoglobinemia with methylene blue